Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Yildirim, Berna; Onal, Cem; Kose, Fatih; Oymak, Ezgi; Sedef, Ali; Besen, Ali; AKSOY, SERCAN; Guler, Ozan; Sumbul, Ahmet; Muallaoglu, Sadik; Mertsoylu, Huseyin; ÖZYİĞİT, GÖKHAN

doi:10.1007/s00066-019-01429-6

Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Yildirim B. A., Onal C., Kose F., Oymak E., Sedef A. M., Besen A. A., ...Daha Fazla

STRAHLENTHERAPIE UND ONKOLOGIE, cilt.195, sa.10, ss.872-881, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 195 Sayı: 10
Basım Tarihi: 2019
Doi Numarası: 10.1007/s00066-019-01429-6
Dergi Adı: STRAHLENTHERAPIE UND ONKOLOGIE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.872-881
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose To evaluate the potential benefit of curative radiotherapy (RT) to the primary tumor in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone.